Introduction
Nasopharyngeal carcinoma (NPC) is a squamous cell carcinoma that usually develops around the ostium of the Eustachian tube in the lateral wall of the nasopharynx. Although NPC is classified as a subtype of head and neck squamous cell carcinoma, its unique epidemiology, clinical characteristics, etiology, and histopathology warrant separate efforts for the study of its underlying molecular mechanism of carcinogenesis [1] . Epstein-Barr virus (EBV) infection, genetic susceptibility, and chemical carcinogens play important roles in the NPC pathogenesis [2] [3] [4] [5] [6] . A variety of proliferative signals are aberrantly activated in the NPC, such as the Akt pathway, mitogen-activated protein kinases, Wnt pathway, and epidermal growth factor receptor signaling pathway [3, [7] [8] [9] . Although some evidence regarding the differential signaling pathway in NPC has been reported, the global pathways affected in the EBV associated NPC is not fully understood.
With the advance of the human genome project, a large amount of information is available for surveying the physiological and pathological processes of humans at global levels. Microarray is a powerful technology developed recently to identify and isolate differentially expressed genes [10] [11] [12] . In previous studies, the classical approach to NPC microarray analysis is to treat genes as independent agents, to apply some statistical test to per gene and follow that up with some form of P-value correction method, but not to analyze the pathway as a whole. Gene set enrichment analysis (GSEA) [13] [14] [15] is a microarray data analysis method that uses predefined gene sets and ranks of genes to identify significant biological changes in microarray data sets. Meanwhile, the method derives its power by focusing on gene sets, that is, groups of genes that share common biological function, chromosomal location, or regulation, and cover a wide variety of biological categories and pathways.
In the analysis of clinical tumor specimens in our former and other studies, a significant confounder is the cellular heterogeneity of normal and diseased tissues. To overcome this problem, microdissection was developed to analyze the clinical samples [16, 17] . Therefore, in this study, we used microarray analysis combined with laser microdissection and GSEA to identify differential signaling pathways in the EBV-associated NPC.
Materials and Methods

Samples
For gene expression analysis, 10 non-cancerous nasopharyngeal epithelium (NPE) and 22 NPC biopsies were collected from Xiangya Hospital in 2003. Each biopsy sample was divided into two sections: one section was routinely stained with hematoxylin and eosin and the other was immersed into the RNALater reagent (Qiagen, Carlsbad, USA) at -808C ready for microdissection. For preparation of the NPC tissue microarray (TMA), 448 patients with NPC and non-cancerous NPE with information such as name, sex, age, race, pathological diagnosis, tumor, nodal, and metastasis, as well as viral capsid antigen (VCA)-IgA, were collected between January, 2002 and Octobor, 2004 at Xiangya Hospital ( Table 1) . For real-time RT-PCR, five histologically normal NPEs and seven NPC biopsies were collected from Xiangya Hospital. All the individuals participating in this project signed the informed consent.
Microdissection, RNA extraction, RNA amplification, and hybridization Microdissection of 22 NPCs and 10 non-cancerous NPE tissues was performed as described previously [18] .
Total RNA was extracted from the microdissection samples with RNeasy w Mini Kit (Qiagen), according to manufacturer's instructions.
A 200 ng aliquot of total RNA from each sample was amplified to cDNA using Ambion's Illumina RNA amplification kit following the instructions (Ambion, Austin, USA). In vitro transcription reaction of cDNA to cRNA was performed overnight including biotin-11-dUTP for labeling the cRNA product. Each sample (1500 ng) labeled with cRNA was hybridized to the gene chip containing 8378 full-length or segmental novel and known human genes that were provided by Biostar Gene Technology Co. Ltd., Shanghai, China.
Pre-processing of gene chip data
The results of hybridization were scanned using the computer system (ScanArray 4000, General Scanning Inc., Bedford, USA). Primary data collection and analysis were carried out using Genepix Pro 3.0 (Axon Instruments, Foster City, USA). The area of the array with obvious blemish was manually flagged and excluded from subsequent analysis. To minimize artifacts arising from low expression values, only genes with raw intensity values for both Cy3 and Cy5 of .200 counts were chosen for differential analysis. Then overall intensities were normalized with a correction coefficient obtained using the ratios of these genes. Genes with ,70% of measurements across all the samples were excluded from the following GSEA. Finally, of 8378 genes, 7007 passed this variation filter. Pathway analysis by GSEA Pathway analysis of the expression data was performed using GSEA implemented in javaGSEA application, version 1.0 [14] . Gene sets for GSEA were taken from Database C2 of MSigDB, version 2.0 (http:// www.broad.mit.edu/cancer/software/gsea/wiki/index.php/ Msigdb_v2_release_notes) of January 2007. This catalog includes 1687 gene sets in which several gene products are involved in specific metabolic and signaling pathways. Briefly, the GSEA algorithm ranks all array genes according to their expression under each experimental condition. Moreover, GSEA integrates the known knowledge of a gene's functional role with the expression data to detect concerted expression changes in a set of genes responsible for producing a phenotype.
RT -PCR analysis
Reverse transcription was carried out as described previously [19] . After the reverse transcriptase reaction, PCR was performed at 948C for 5 min, then 38 cycles at 948C for 45 s, 558C for 45 s, and 728C for 1 min followed by 728C for 7 min. RT-PCR were repeated at least three times to avoid false-positive results. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an endogenous control for normalization. The primer sequences of the EBV nuclear antigen 1 (EBNA1) and GAPDH used for RT-PCR were as follows: EBNA1 TMA construction TMA was constructed as described in our previous study [2] . A total of 448 tissue cores representing 448 patients were placed in one TMA block. The tissue core numbers on each section were slightly different because of additional losses suffered from block trimming and staining procedures.
In situ hybridization and immunohistochemistry (IHC) The DIG olignucleotide 3 0 -tailing labeling kit was purchased from Roche (Basel, Switzerland) and the in situ hybridization (ISH) method was the same as in our previous study [2] . Immunohistochemistry (IHC) studies were performed using the standard streptavidin/peroxidase staining method as described previously [2] . As many literatures have reported that NPC is closely associated with EBV, we took advantage of the high-throughput TMA to detect EBV-encoded small RNA-1 (EBER-1) using ISH. The EBER-1 probe was 5 0 -AGACACCGTCCTCACCACC CGGGACTTGTA-3 0 . These antibodies included monoclonal mouse antihuman p16, 1:100 (clone F-12, Santa Cruz Biotechnology, Santa Cruz, USA); p19INK4d, 1:100 (clone DSC-100, NeoMarkers, Fremont, USA); p27, 1:100 (clone DCS-72, NeoMarkers); Rb, 1:100 (clone CH18-0159, ZYMED, San Diego, USA); CDK4, 1:100 (clone DK4-CT, NeoMarkers); cyclin D1, 1:100 (Santa Cruz ), and polyclonal antibodies such as CDK8, cyclinC, DP2, E2F6, and phosphorylated Rb from Neomarkers. All known positive sections were taken as positive controls. Negative mouse serum and PBS were used instead of first antibody as negative control and blank control, respectively. A semiquantitative scoring criterion for ISH and IHC was used, in which both staining intensity and positive areas were recorded.
Survival analysis
There were follow-up data for 115 patients. Overall survival (OS) was defined as the time of diagnosis to date of death. Event-free survival (EFS) was defined as the time of diagnosis to date of first failure. The OS and EFS estimates over time were calculated using the Kaplan-Meier method and differences were compared using the log-rank test. Results of the analysis were considered significant in a log-rank test if P , 0.05.
Statistical analysis
Associations between clinicopathological parameters and the cell cycle regulators such as p16, CDK4, cyclin D1, Rb protein (pRb), and so on, were evaluated using the Pearson x 2 -test or Fisher's exact test. Spearman correlation test was used to evaluate the pair-wise association of EBER-1 and cell cycle regulators in NPC. We used the standard logistic regression model to analyze EBER-1 and cell cycle regulators in NPC carcinogenesis. Real-time PCR (RT-PCR) results were evaluated using Student t-test. Calculations were performed using the SPSS 13.0 statistical software for Windows. P , 0.05 is considered statistically significant, and all statistical tests were two sided.
Results
Detection of EBNA1 expression of the samples served in the microarray analysis by RT-PCR and EBER-1, LMP1 expression using NPC-specific TMA In this study, all NPC specimens served in the cDNA microarray analysis were positive for EBV, as judged by identification of the expression of EBNA1 (Fig. 1) . Furthermore, we detected the association between EBV infection and VCA-IgA titer. In the 231 NPC patients, the positive rate of VCA-IgA was 86.1% (199/231), suggesting 86.1% NPC patients had the EBV infection. Nuclear EBER-1 expression was detected in 68.6% (127/ 185) NPC cases by ISH [ Fig. 2(A,B) and 3]. The expression of LMP1 detected by IHC in NPC patients was over 78%. These results suggested a strong association between EBV infection and NPC.
Cell cycle pathway: the most disregulated pathway in NPC tissues revealed by GSEA In order to understand the globally affected pathways associated with NPC, we performed the cDNA microarray analysis in 10 non-cancerous NPEs and 22 NPC tissues by laser microdissection and GSEA [14] . Our results suggested that the cell cycle pathway was the most disregulated pathway in NPC according to the criteria (normalized enrichment score, NES ¼ 22.22; NOM P, the uncorrected P ¼ 0.000; false discovery rate (FDR) q-value ¼0.001) recommended by Subramanian et al. [14] ( Table 3 ). The expression of the cell cycle pathway related genes correlated with phenotype noncancerous NPE and NPC could be seen in Fig. 4 . As the G1-S phase members of the cell cycle pathway, p16 and p27 were down-regulated in NPC tissues, whereas TP53, CDK4 and RB1, were up-regulated in NPC tissues in our gene chip data ( Table 4) .
Quantitative expression level of differential expression genes validated by real-time RT-PCR To determine the reliability of our gene chip data, we confirmed our microarray results by quantitative real-time RT-PCR analysis. A higher Ct value indicated less RNA copy in original samples, as more cycles were required to reach the same RNA density point on the graph. Compared with non-cancerous NPE tissues, CDK4, Rb, and cyclin D1 genes were found significantly up-regulated (P ¼ 0.008, 0.006, and 0.035, respectively); p16, p27, and p19 genes were significantly downregulated in NPC tissues (P ¼ 0.006, 0.000, and 0.007, respectively). However, the expression of CDK8 and DP2 mRNA was not statistically significant ( Table 5) .
Protein expression of cell cycle regulators using NPC-specific TMA The overexpression of cyclin C, CDK8, and E2F6 protein could be seen in NPC, histologically normal NPE, and dysplastic NPE, but no differences were seen between them. In different clinical stages, cervix lymph node metastasis, and NPC pathogenic subtypes, no statistical difference of p16, p27, p19, CDK4, cyclin D1, Rb, and DP2 expression was found (data not shown). Some of the most striking findings were the loss of p16, p27, and p19 expression in NPC and the overexpression of cyclin D1, CDK4, and Rb in NPC. Representative images could be seen in Fig. 2 .
Among the down-regulated proteins, the expression rate of p16 in NPC samples, in dysplastic NPE samples, and in histologically normal NPE samples was 47.4%, 64.3%, and 82.3%, respectively (P ¼ 0.025, 0.013, and 0.000); Moreover, for p27 and p19, the expression rates were 50.5%, 56.9%, 74.2% (P ¼ 0.389, 0.029, and 0.000); and 49.8%, 52.6%, 72.1% (P ¼ 0.701, 0.017, and 0.001), respectively. Among the up-regulated proteins, the expression rate of cyclin D1 in NPC samples, in dysplastic NPE samples, and in histologically normal NPE samples was 91.9%, 81.4%, and 71.7%, respectively (P ¼ 0.019, 0.180, and 0.000). The expression rate Fig. 3 Abnormal expression of EBER-1 hybridization signals and cell cycle regulators in histologically normal NPE, dysplastic NPE, and NPC Comparison of abnormal expression of EBER-1 hybridization signals, p16, p27, p19, CDK4, cyclin D1, Rb, DP2, and E2F6 proteins between NPC and various types of non-cancerous NPE. Here P-value denotes significant differences between the groups statistically evaluated by x 2 test. Size, number of genes in the gene set; ES, enrichment score; NES, normalized enrichment score; FDR q-value, false discovery rate and multiple testing corrections (q-value); NOM P-value, the uncorrected p-value.
Aberrant cell cycle regulation in NPC for Rb, CDK4, and DP2 was 90.6%, 70.9%, 56.3% (P ¼ 0.000, 0.084, and 0.000); 62.7%, 51.9%, 46.2% (P ¼ 0.144, 0.511, and 0.007); and 94.7%, 87.9%, 85.3% (P ¼ 0.080, 0.642, and 0.006), respectively (Fig. 3) .
Simultaneously, we compared the abnormal expression of p16, CDK4, cyclin D1, Rb, DP2, E2F6, p19, and p27 proteins between NPC and the matched adjacent epithelia of NPC ( Table 6 ). Significant differences were observed in p16, p27, p19, CDK4, cyclin D1, and Rb proteins (P ¼ 0.005, 0.007, 0.030, 0.028, 0.004, and 0.000, respectively), but no statistical difference was seen in E2F6 and DP2 proteins. Table 7 . In NPC, the expressions of Rb, cyclin D1, and CDK4 were strongly and positively correlated with EBER-1 hybridization signals (P ¼ 0.000 for Rb, P ¼ 0.000 for cyclin D1, and P ¼ 0.000 for CDK4), whereas the expression 
Cluster analysis and display
We used an unsupervised hierarchical clustering algorithm [20] to analyze and visualize the data generated in this pilot study using NPC-specific TMA. The results are presented graphically in Fig. 5 . Using the twodimensional clustering algorithm for both protein expression and tumors, we could cluster the protein biomarkers according to the similarity of their expression patterns in tumors and the tumors based on the similarity of expression of different biomarkers. The 11 protein biomarkers were clustered into two groups. The first was a 'proliferation-related' cluster that included CDK8, cyclin D1, phosphorylated Rb, DP2, E2F6, Rb, cyclin C, and CDK4. The second was cyclin-dependent kinases inhibitors (CDKIs) family that included p27, p19, and p16. Also the nasopharyngeal specimens were clustered into two main groups. The first cluster was mainly composed of NPC with the loss of expression of p27, p19, and p16 proteins, and the overexpression of cyclin D1, Rb, CDK8, and DP2. The second cluster was histologically normal NPE and atypical hyperplastic NPE with high expression of p27, p19, and p16, whereas the low expression of cyclin D1, CDK4, and CDK8, respectively.
Survival analysis of cell cycle regulators in NPC patients
Among these cell cycle regulators, only cyclin D1 could be the prognosis biomarker for NPC patients. EFS of NPC patients with cyclin D1 positive expression was significantly higher than those with cyclin D1 negative expression (60.6 vs. 30.0%, P ¼ 0.049). However, the OS was not significantly different between the cyclin D1 positive expression and the cyclin D1 negative expression group (69.1% vs. 60.0%) (Fig. 6) .
Discussion
This study revealed activation of globally affected differential signaling pathway by cDNA microarray and GSEA, and found that the cell cycle pathway was the most disregulated signaling pathway in EBV-associated NPC.
The classical approach to DNA microarray analysis has been to treat genes as independent agents, to apply some statistical tests to per gene and follow that up with some forms of the P-value correction method. GSEA [13] [14] [15] is supplementary to single-gene approaches, and provides a framework with which we may examine changes at a higher level of biological organization. Gene-set analysis evaluates the expression of biological pathways or previously defined gene sets, rather than that of individual genes, in association with a binary phenotype, and is of great biologic interest in many DNA microarray studies. GSEA has been applied widely as a tool for gene-set analysis. In this study, we used GSEA to analyze the microarray data in the gene set of 0.000 *Correlation is significant at the 0.05 level (two-tailed); **correlation is significant at the 0.01 level (two-tailed). B, the coefficient for the constant; SE, standard error; Wald, the Wald chi-square test; df, degree of freedom; significance, the P-value; Exp (B), the exponentiation of the B coefficient (odds ratio). Red means strongly positive, brown means weakly positive, green means negative, and black means data not present. For each tumor, the protein expression score is represented by the color of corresponding cell in the matrix. The length and pattern of the branches of the vertical and horizontal dendrograms reflect the similarity between the tumors and the similarity between the markers, respectively. The shorter the arm of the branches, the greater the similarity of the cases and markers. Database C2 of the MSigDB version 2.0 in which most pathways are concerned specific metabolic and signaling pathways. The results showed that cell cycle pathway was the most disregulated pathway with a nominal P-value of 0.000, enrichment score (ES) of 20.69, NES of 22.22, FDR q-value of 0.001, suggesting that the cell cycle pathway was closely associated with NPC development.
The mechanism of cell cycle regulation is the reciprocity of cyclins, cyclin-dependent kinases (CDKs), and CDKIs [21] . Alterations of any component of the pathway, such as deletion or mutation of the p16 gene, amplification or the overexpression of CDKs of cyclin D, and mutations to CDKs that affect p16 binding, will lead to Rb phosphorylation and subsequent progression of G1 into S phase transition [22, 23] . These alterations have been found in many human tumors, suggesting that inactivation of the cell cycle pathway may play an important role in their pathogenesis, but detailed and comprehensive explanation about the aberrant activation of cell cycle pathway in NPC have not yet been reported.
In this study, some members of the cell cycle pathway had been screened by analyzing the gene expression profiles of NPC, using GSEA software and confirmed by the quantitative real-time RT-PCR and TMA at the mRNA and protein levels of p16, p27, p19, Rb, CDK4, cyclin D1, CDK8, cyclin C, E2F6, phosphorylated Rb, and DP2. In our work, loss of p16 expression was observed in NPC specimens compared with histologically normal NPE, dysplastic NPE, and the matched adjacent epithelia of NPC. Loss of p16 expression in dysplastic NPE was also lower than that in histologically normal NPE. These findings accorded with other previously reported results [2, [24] [25] [26] [27] [28] , suggesting that inactivation of p16 gene might be the early molecular event of nasopharyngeal carcinogenesis and might significantly correlate with the development of NPC. However, in our study there existed the overexpression of EBV LMP1. Zhao et al. [29] had reported that LMP1 could inhibit p16 expression, induce pRb phosphorylation, up-regulate E2F1 transactivity and expression, and promote the progression of G1/S phase. Song et al. [30] reported that the decrease of p16 cooperated with cyclin D1 and caused deregulation of G1/S checkpoint, leading to abnormal cell proliferation in NPC. However, the precise mechanism of p16 inactivation in NPC is not clear. It may be inactivated through homozygous deletion, promoter hypermethylation, and point mutation [31] . Our current data of multivariate analysis showed that p16 was an independent predictor of nasopharyngeal carcinogenesis. The present study suggested that p27 protein expression was reduced in NPC specimens and dysplastic NPE compared with histologically normal NPE, which is in accordance with previous reports [2] . Loss of p27 protein expression may result in tumor development and/or progression; however, this loss of expression does not appear to be resulted from gene mutations according to some studies [32, 33] . Oh et al. [34] reported an association between p27 and cyclin D1 expression, which indicated that the balance between the two opposing regulators was important for the end result of cell cycle progression. cyclin D1 is an important member of cell cycle pathway, so we decided to look at its expression though there was not any clone representing the cyclin D1 gene in this cDNA microarray. The positive expression rate of cyclin D1 protein in NPC tissues was as high as 91.9%, consistent with the previous report [35] . Multivariate analysis showed that cyclin D1 was an independent predictor of nasopharyngeal carcinogenesis. Despite advances in imaging technology and treatment techniques, about 50% of patients had NPC recurrence after receiving adequate treatment for the nasopharynx. This highlights the importance of cyclin D1 in early prediction of recurrence of NPC [24] . Some studies have provided in vivo evidence demonstrating that low levels of cyclin D1 are associated with ipsilateral breast cancer and early-stage laryngeal cancer recurrence following radiation therapy [36, 37] . Our data suggested that patients with positive expression of cyclin D1 protein had better prognosis than those with negative expression of cyclin D1, indicating that cyclin D1 protein expression may be useful as a predictor of local tumor control in NPC. Zhao et al. [38] reported that LMP1 could up-regulate the transcription of cyclin D1 through NF-kB signaling pathway, thus promoting the transition of the cell cycle from G1 to S phase, and leading to premature S phase entry. Hui et al. [28] revealed that both inactivation of p16 and activation of cyclin D1 might be important in the alteration of cell cycle controls and development of NPC. Some papers [39, 40] reported that EBV LMP1 could increase CDK4 expression, promote its nuclear translocation, and induce cyclin D1 expression. The expression of CDK4 was much higher in NPC than in histologically normal NPE. The activity of CDK4 kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16 (INK4a). This kinase was shown to be responsible for the phosphorylation of Rb protein.
The increases of cyclin D1 and CDK4 expression were Aberrant cell cycle regulation in NPC found to be associated with tumorigenesis of a variety of cancers [41] [42] [43] [44] . In addition to this, our data suggested that 90.6% of the NPC specimens expressed Rb, which was much higher than the matched adjacent epithelia of NPC, histologically normal NPE, and dysplastic NPE. However, immunohistochemical stains are blind to the phosphorylation status of Rb, so identification of Rb in tissue sections does not exclude functional inactivation of this protein. Chen et al. [45] had suggested that NPC transformation depended on timely regulation of Rb and several transcriptional cascades, interconnected by E2F, AP-1, NF-kB, and STAT3 among others during latent and lytic cycles. Multivariate analysis showed that Rb was an independent predictor of nasopharyngeal carcinogenesis. Furthermore, unsupervised hierarchical clustering in NPC-specific TMA revealed that one group belonged to the CDKI family, which included p27, p19, and p16; whereas the other group was 'proliferationrelated' proteins that included CDK8, cyclin D1, DP2, E2F6, Rb, cyclin C, phosphorylated Rb, and CDK4. If the expression of these proteins is viewed together, most tumors contained abnormal expression of at least one of p16, cyclin D1, CDK4, and Rb. This revealed that cell cycle progression is regulated not by a single cell cycle regulator, but by a balance of negative and positive regulators. This observation confirms the fundamental role of the p16-cyclin D1/CDK4-Rb pathway in NPC tumorigenesis.
As many studies [39, [46] [47] [48] [49] [50] and our previous studies [2, 3] had reported that NPC was closely associated with EBV infection, and all NPC specimens served in the cDNA microarray analysis were positive for EBV. It was reported [3, 51] that EBNA1 was consistently expressed in NPC tumors and was a useful marker in the clinical treatment of NPC. The expression of EBNA1 in this study confirmed that EBV infection was consistently observed in all NPC samples. Furthermore, we detected the expression of EBER-1 and LMP1, together with those abnormally expressed genes, which were included in the cell cycle pathway using NPC-specific TMA. Our result suggested that the expression of EBER-1 and LMP1 existed in most of NPC patients. As for the relationship between abnormally regulated cell cycle pathway and EBV infection, we found that in NPC, EBER-1 was strongly and positively correlated with CDK4, cyclin D1, and Rb expression, yet negatively correlated with the p16 expression, suggesting that the abnormally regulated cell cycle pathway might be associated with EBV infection. Through multivariate analysis, we found that EBER-1 was the most significant and independent predictor of nasopharyngeal carcinogenesis from the non-cancerous NPE to NPC. These findings suggested a strong association between EBV infection and abnormally regulated cell cycle pathway in NPC, but the exact mechanism needs further study.
In summary, we combined the cDNA microarray with microdissection to comprehensively analyze the gene expression profiles between NPC and non-cancerous NPE samples. Using GSEA algorithm, we found that the cell cycle pathway was the most disregulated pathway in NPC samples. Abnormally activated cell cycle pathway was identified to be potentially biologically meaningful in NPC by NPC-specific TMA. 
